doi: 10.1161/01.CIR.0000036741.27574.CE
(Circulation. 2002;106:2173.)
© 2002 American Heart Association, Inc.
Special Report |
The Electrocardiogram 100 Years Later
Electrical Insights Into Molecular Messages
From the Department of Pharmacology, College of Physicians and Surgeons of Columbia University, New York, NY.
Correspondence to Michael R. Rosen, MD, Gustavus A. Pfeiffer Professor of Pharmacology, Professor of Pediatrics, Director, Center for Molecular Therapeutics, College of Physicians and Surgeons of Columbia University, 630 West 168 St, PH7West-321, New York, NY 10032. E-mail mrr1{at}columbia.edu
In 1921, Willem Einthoven invited Thomas Lewis to lecture in Leiden. Lewis responded, "The Leiden visit is one to which I am looking forward with great pleasure. It will be most stimulating to come to the Mecca of electrocardiography ..."1 It is with much the same feeling that I approach this lectureship, honoring the memory of the man who, in developing the ECG, in effect ushered in the modern era in electrophysiology. In being here, I also pay homage to the Dutch tradition of electrophysiology, which has flourished since Einthoven’s time.
In 1930, several years after Einthoven’s passing, the Russian electrophysiologist Samojloff was invited by Paul Dudley White (later the first Einthoven Lecturer) to reminisce about Einthoven’s contributions. Samojloff stated, "... Einthoven worked almost exclusively in the field of electrophysiology. This branch of physiology stood for a long time completely isolated from life, medicine, and even from the general path of development of physiological knowledge; shut off in this way, electrophysiology could not progress and it seemed that it would be difficult to alter this sad situation of the study of animal electricity. [Einthoven’s mind] ... worked like an instrument of precision. He worked only on what could be measured and his measurements reached the limit of precision possible under the circumstances."2
Einthoven’s string galvanometer was remarkable in the fidelity and accuracy of its recordings and in its utility for interpreting the rhythm and state of health of the heart. Moreover, in applying the instrument to diagnosis, Einthoven foresaw events that wouldn’t occur again for 50 years or more. Not only were patients’ ECGs recorded, but the signals were wired the 1-mile distance from hospitalized patient to laboratory for registration and analysis. The off-site diagnostician was often able to identify a patient’s affliction faster than the on-site physician.3
Einthoven assessed the value of his invention rigorously; in 1922, he wrote to Lewis, "An instrument takes its true value not so much from the work it possibly might do but from the work it really does."4 A very practical approach, and in 1922 the ECG did more than enough to justify its use. Yet, we can only wonder whether a visionary like Einthoven or, indeed, anyone at that time, could foresee how much more the instrument held in store. Certainly, Lewis was not a visionary in this instance. In 1925, he diverted his attention from electrocardiography because he was "weary of being tied to an instrument ... the cream was off ... there were no longer new things to be discovered in electrocardiography."5
Yet, during this period, electrocardiography was not only advancing, but exploration of its possibilities ushered in vectorcardiography,6 phonocardiography,7 and application to other organ systems that emit electrical signals.8 Moreover, electrocardiography has remained a centerpiece of clinical and investigative cardiology since its invention. For example, although nothing might be further from the interests of molecular biologists and geneticists than to register and interpret ECGs, those using mouse models to genetically manipulate cardiac proteins9 find the ECG a prime tool in their armamentarium. Also, as shall be described, their clinical counterparts have found diagnostic clues within the ECG’s simple waveforms that reflect highly specific protein alterations in the heart.
The ECG as Molecular Messenger: Early Insights
It is difficult to date the origins of our understanding that electrocardiographic signals may reflect molecular change. That the ECG sums electrical activity generated by billions of cardiac myocytes was recognized from the time investigators began to record action potentials from cardiac cells.10 Adaptation of voltage clamp and single channel recording techniques to the heart heightened our appreciation of the roles of the cell membrane’s integral proteins in generating action potentials. Studies of such inherited conditions as congenital long QT syndrome (LQTS)11–13 demonstrated that some genetic anomalies are expressed phenotypically on the ECG.
Exemplifying the burgeoning awareness of relationships between molecular change and repolarization was Peter Schwartz’s statement in 1986 that "The LQTS may be due to a primary abnormality in myocellular repolarization as a result of genetic alteration in the voltage dependent protein which regulates outward potassium current during phase 3 of the action potential."14 The possibility that different genetic variants of LQTS might be reflected in different repolarization patterns on the ECG was demonstrated by Moss et al in 1995.15 Although prediction of genotype by electrocardiographic phenotype was imperfect, subsequent investigation has suggested that it is often accurate.
Investigators had earlier learned that the T wave reflects transmural and apico-basal gradients for ventricular repolarization16–18 and commenced to design frameworks for exploring the molecular determinism of the T wave19–22 (Figure 1). The results enabled scientists to link the structures of some protein subunits to their biophysical functions and to the ultimate expression of these functions in a cell or in the heart in situ.21–24 It is now only a matter of time before we unravel the needed information about all contributing structures. This might have been a rash prediction a decade ago; now, it is simply inevitable.
|
My initial recognition of this possibility was fueled by discussions with my mentor, Brian Hoffman, and was further directed by Mauricio Rosenbaum. Mauricio had been intrigued by observations of Chatterjee et al25 in patients manifesting persistent postpacing changes in T-wave morphology. Similar changes had been described in intermittent left bundle branch block, post-tachycardia syndromes, extrasystoles, and ventricular preexcitation.26–34 The fundamental observation that paced or spontaneous ventricular impulses could result in ST-T wave changes that persisted after returning to sinus rhythm was expanded and formalized by Rosenbaum and coworkers.35,36 Given that the T waves of the subsequent sinus beats followed the same vector as the paced or ectopic QRS complex, the provocative term "cardiac memory" was suggested; the T wave "remembered" the ectopic QRS.
Mauricio and I would meet regularly on his trips to New York; we sat at the Algonquin’s weathered tables, sipped coffee, and discussed life and research. What I cherished most about those afternoons was Mauricio’s generosity as teacher, confidante, and friend. With respect to research, I was especially intrigued by his thoughts regarding cardiac memory. Yet whenever I considered designing protocols to follow-up on these, other commitments seemed to intervene. Then, one day Mauricio said, "Mike, you’re getting older. You’d better start studying memory while you still have one." I’ll now review what we have learned of the association of molecular message with electrical signal, using Einthoven’s ECG to take Rosenbaum’s advice.
The ECG of Cardiac Memory and Its Ionic and Molecular Determinants
Our studies of cardiac memory have been performed entirely in the dog and rat. When asked why not the human, I think of the remark attributed to Albert Szent-Gyorgi, "Life is a similar process in cabbages and kings; I choose to work on cabbages because they are cheaper and easier to come by."37 We can readily and reproducibly induce memory in canine heart via the use of cardiac pacemakers and, while the rat does not provide a T wave adequate for human application, it does permit us to explore pacing-induced molecular changes in a system presently more accessible to molecular/genetic study than the dog.
Figure 2 depicts cardiac memory in a dog paced from the ventricle at a rate slightly faster than sinus for several weeks. On reversion to sinus rhythm, the T wave follows the direction of the paced QRS complex and persists in that pattern for long periods. No pathology, hypertrophy, hemodynamic, or circulatory change accompany this T-wave pattern,38 and it is altered activation, not increased heart rate, that induces cardiac memory.38–40
|
Most of our work on cardiac memory has been in dogs such as those in Figure 2, paced for weeks and showing stable, persistent repolarization changes.38,41,42 Our initial goal was to test the relationship between the T-wave change and the transmural repolarization gradient; one of whose determinants, the transient outward potassium current, Ito, is large in ventricular epicardial myocytes and small in endocardium.43,44 Figure 3 demonstrates that cardiac memory is associated with decreases in Ito density and mRNA for Kv4.3 (which encodes the 
-subunit of the channel protein41) and a reduction in the epicardial action potential notch (determined by Ito). Also altered are Ito kinetics; activation voltage shifts positively, and recovery from inactivation prolongs about 20-fold.41 Accompanying these molecular/biophysical changes is an altered transmural repolarization gradient (Figure 3).41
|
If Ito is a major factor in induction of cardiac memory, then its absence should prevent memory from occurring. We tested this supposition by administering the Ito blocker 4-aminopyridine to intact dogs39 or isolated tissues,45 after which memory could no longer be induced. The role of Ito was also tested using a developmental approach, deriving from our earlier observation that myocytes from dogs under two months of age do not manifest Ito or a phase 1 notch.46 The magnitude of the memory induced increased in parallel with evolution of the phase 1 notch over the first 120 days of life.47
However, Ito is not the only current to change in cardiac memory. ICa,L density is comparable to controls, but its activation and recovery from inactivation are altered in a manner consistent with the elevation and prolongation of the action potential plateau (Figure 3A).48 Memory is also associated with reduction in density of the gap junctional protein connexin43 (Cx43) and with changes in Cx43 distribution, from concentration at the longitudinal poles of myocytes to more uniform patterning across the lateral cell margins.49 These changes in Cx43 are regionally nonuniform; ie, they are greater epicardially than endocardially and near to rather than far from the pacing electrode.49 These factors likely all contribute to the altered transmural repolarization gradient.
How Are Pacing-Induced Signals Transduced?
Understanding the transduction of signals requires a road map, commencing with cellular excitation and terminating at end-organ response. We know that pacing the ventricle alters its pathway for activation and stress/strain relationships in the myocardium.50–52 We also know that changing stress/strain relationships on cardiac cell cultures increases release of angiotensin II,53,54 a hypertrophic hormone that modulates cardiac electrical activity and structure.55,56 Experiments on memory of short duration in dogs demonstrated that ACE inhibition or AT-1 receptor blockade prevent its initiation.52 Moreover, incubation of epicardial ventricular myocytes from control dogs with angiotensin II for hours/days results in changes in the action potential notch and Ito magnitude and kinetics identical to those described above for cardiac memory.57 Together, these results suggest a central role for angiotensin II in the genesis of cardiac memory.
However, the story is more complex. Despite the effect of angiotensin-converting enzyme (ACE) inhibition or AT-1 receptor blockade to attenuate memory initiated by brief periods of pacing, neither intervention prevents the effects of 3 weeks of pacing to induce memory of long duration (unpublished data). This suggests that while angiotensin II may initiate memory, it does not sustain the process of accumulation. In seeking other processes involved, a significant role for calcium has been uncovered. Specifically, administration of ICa,L blockers suppresses memory induced by brief or protracted periods of pacing (preliminary data). The Ca-associated effect is not altered by ß-adrenergic blockade, and may be triggered by another process (perhaps angiotensin II’s effect to increase ICa,L).58
Another complexity is that Kv4.3 mRNA is unchanged in myocytes exposed to angiotensin II,57 in contrast to pacing-induced memory for which Kv4.3 mRNA is reduced.41 If angiotensin II were truly responsible for pacing-induced memory, then angiotensin II might be expected to reduce Kv4.3 mRNA (which does not occur) or to initiate other processes that reduce either Kv4.3 message or protein. Recent data suggest angiotensin II induces enzymes involved in protein degradation via a negative feedback loop, regulating and limiting hormonal production.59 Such degradation could explain the reduced message for Kv4.3 in our pacing studies but not the failure to see a reduction of Kv4.3 when myocytes are incubated in angiotensin II. Whether additional changes occur at the level of channel protein synthesis and/or phosphorylation needs to be tested, as does the possibility that the changes seen in memory result from accelerated protein degradation.
In summary, we initially hypothesized angiotensin II to be the sole initiator of cardiac memory. The temptation was then to see all of memory as evolving from this single initiator. The problem was that some of our data were at variance with our initial idea, prompting much discussion and some confusion within our research team. Einthoven (quoted by Carl Wiggers)60 had advice to give on this subject: "When evidence is at variance ... spend more time in attempting to harmonize differences rather than ... direct ... energies toward procurement of more data for a favored hypothesis. The truth is all that matters; what you or I think is inconsequential."
Neurons as Paradigms: the Role of Nuclear Factors
Thus far, I have described a partially tested and circumscribed role for angiotensin II and a more diverse but as yet uncharted role for Ca in cardiac memory. In seeking an interface with transcriptional elements in the heart, we adopted memory in the central nervous system as a paradigm, particularly, studies in the sea slug aplysia used by neuroscientists to study long-term facilitation. Facilitation is induced in aplysia by electrical shocks or serotonin administration, both of which initiate phosphorylation and synthesis of the cAMP response element binding protein (CREB), a pivotal transcriptional factor in the synthesis of new protein that sustains memory.61–63 Initiation of memory commences rapidly after stimulation, such that a single electrical shock or pulse of serotonin exerts a measurable effect, the magnitude of change of which increases over minutes.
Whereas in the central nervous system (CNS), processes involved in long term facilitation are initiated and up-regulated over seconds to minutes, cardiac memory appears to be more associated with down-regulation than synthesis (eg, Ito,41 Cx4349). Although CREB phosphorylation initially increases on pacing the canine or rat heart,64,65 pacing the dog for 120 minutes results in decreased CREB levels.65 The CNS parallel, then, might be long-term depression instead of facilitation.
Decreases in CREB levels might be expected if CREB were an upstream transcriptional factor whose down-regulation were required for expression of cardiac memory or if a factor or factors not yet identified were down-regulating both. That either possibility may prove true is suggested by the identification of an apparent degradation product of CREB increasing in amount as memory evolves and as CREB levels decrease (preliminary data). In any event, the sequence of CREB changes parallels the temporal course of the ECG changes of cardiac memory.65
Clinical Applications of Cardiac Memory
The final point I will consider is the potential clinical meaning of cardiac memory, summarized as responses to four questions:
- (1) To the extent that angiotensin II is involved in at least the onset of memory, might memory be an initial sign of hypertrophy to come? This is possible, although at least two observations are in opposition: (1) the failure to demonstrate long-term involvement of angiotensin II in cardiac memory; and (2) the demonstration of feedback loops that ultimately limit angiotensin II availability.59
- (2) Might cardiac memory impact on antiarrhythmic drug treatment? Ito and IKr-blocking drugs suppress the occurrence of memory, and memory itself (as might be induced by a ventricular arrhythmia) alters the effects of some drugs, eg, quinidine.42 Hence, memory modulation by drugs and the effect of memory to alter drug actions should be considered as determinants of the expression of drug effects.
- (3) Might pacing to induce cardiac memory be antiarrhythmic? We and others have shown that pacing of the sort that induces memory and/or altered stretch can modulate ventricular and atrial effective refractory periods in ways that might be anti- or proarrhythmic.66–68
- (4) Is there atrial memory, and if so, might it impact on atrial arrhythmias?69–71 Figure 4 demonstrates atrial memory in dogs in complete heart block and chronically instrumented with left or right atrial pacemakers. Atrioventricular (AV) sequential pacing is employed to prolong the PR interval, facilitating recording of the Ta wave. We use modified Frank leads to record P and Ta waves and have adapted the concept of the ventricular gradient72–74 to calculate an atrial gradient (AG)69,75,76 as follows:
When animals are paced for two hours at rates about 5% faster than sinus (Figure 4), right atrial pacing is unassociated with a changed atrial gradient, whereas left atrial pacing induces a change that accumulates in magnitude over time and as pacing rate increases. We interpret this phenomenon as atrial memory.69
- (2) Might cardiac memory impact on antiarrhythmic drug treatment? Ito and IKr-blocking drugs suppress the occurrence of memory, and memory itself (as might be induced by a ventricular arrhythmia) alters the effects of some drugs, eg, quinidine.42 Hence, memory modulation by drugs and the effect of memory to alter drug actions should be considered as determinants of the expression of drug effects.
|
Left and, to a lesser extent, right atrial pacing at rates slightly faster than sinus for 3 to 4 weeks induces further changes in atrial gradient.70 Moreover, after 24 hours of right or left atrial pacing, competing atrial tachycardias arise. These persist throughout the pacing period during right atrial pacing and cease when pacing is discontinued. Similar arrhythmias occur during left atrial pacing, but these persist during postpacing recovery and are associated with further change in the atrial gradient.70 Most recently, we have observed that with very rapid atrial pacing (600 to 900 bpm), the atrial gradient continues to evolve until atrial fibrillation occurs.71 At these rapid rates, the atrial gradient is altered regardless of whether pacing is right- or left-sided.71
The key to understanding the potential for diagnostic or predictive use of the atrial gradient is that it begins to change in response to pacing before changes in the effective refractory period are noted.70,71 Hence, change in the gradient may represent a noninvasive "early warning" of impending tachyarrhythmia, including fibrillation. However, before waxing too enthusiastically over possibilities here, I might well paraphrase Einthoven’s admonition quoted earlier;4 the true value of any technique lies not in what it promises but in what it delivers.
Closing Comments
In preparing this talk, I read extensively of Einthoven’s life, reread many of his papers, and reviewed some of his correspondence. What impressed me was not only the exemplary caliber of his work but the very human and thoughtful qualities that were commented on by his contemporaries and that come across so clearly in his writings. A characteristic especially meaningful to me has been Einthoven’s profound sense of internationalism, which is all the more remarkable in that it persisted through the years leading to, during, and following the Great War. This sentiment is evidenced with exceptional clarity in the closing words of Einthoven’s Nobel Prize lecture77: "... a new chapter has been opened in the study of heart diseases, not by the work of a single investigator, but by that of many talented men, who have not been influenced in their work by political boundaries and, distributed over the whole surface of the earth, have devoted their powers to an ideal purpose, the advance of knowledge by which, finally, suffering mankind is helped."
As noted by so many in electrophysiology, some of our closest personal and professional bonds and some of our finest moments have been achieved in the company of others born far from us and often living far from us. If ever there were a model demonstrating that disparate peoples can find common ground and kinship despite the distances of culture and personal belief, then our field has shown this, as Einthoven recognized a century ago and as is apparent to this day. With these sentiments in mind, I would like to acknowledge and thank the diverse cast of students, fellows, and faculty who have contributed enthusiastically and selflessly to the work reported here (and whose names may be found in the references), and the larger community of colleagues who have made this career so rewarding.
Acknowledgments
My thanks to Charlie Antzelevitch, Martin Schalij, Peter Schwartz, and Albert Waldo, who found background materials for me; to Ira Cohen, Peter Danilo, David McKinnon, Richard Robinson, and Susan Steinberg, my long-term partners in program research; and Eileen Franey for her careful attention to the preparation of the manuscript. Finally, my special thanks to the National Heart, Lung and Blood Institute, whose support over the years has enabled the performance of our research.
Footnotes
This is the abridged text of the 23rd Einthoven Lecture delivered by the author on receipt of the Einthoven Award, June 10, 2002. The lecture was delivered at a symposium under the auspices of the Einthoven Foundation and the University of Leiden, celebrating the 100th anniversary of Willem Einthoven’s invention of the electrocardiogram.
References
1. Lewis T. Quoted by: Snellen HA. Two Pioneers of Electrocardiography. Rotterdam, the Netherlands: Donker Academic Publications; 1983: 100.
2. Samojloff A. Reminiscences of the late Professor Willem Einthoven. Am Heart J. 1930; 5: 545–548.[CrossRef]
3. Einthoven W. Le télécardiogramme. Arch Internat Physiol. 1906; 4: 132–164.
4. Einthoven W. Quoted by: Snellen HA. Two Pioneers of Electrocardiography. Rotterdam, the Netherlands: Donker Academic Publications; 1983: 48.
5. Lewis T, Quoted by: Snellen HA. Two Pioneers of Electrocardiography. Rotterdam, the Netherlands: Donker Academic Publications; 1983: 26.
6. Williams HB. On the cause of the phase difference frequently observed between homonymous peaks of the electrocardiogram. Am J Physiol. 1914; 35: 292–300.
7. Einthoven W. Die Registrirung der menschlichen herztöne mittels des saitengalvanometers. Arch ges Physiol. 1907; 117: 461–478.[CrossRef]
8. Einthoven W, Jolly WA. The form and magnitude of the electrical response of the eye to stimulation by light at various intensities. Quart J Exper Physiol. 1908; 1: 373–416.
9. Rakhit A, Berul CI. Transgenic electrophysiology and small animal models. In: Spooner PM, Rosen MR, eds. Foundations of Cardiac Arrhythmias. New York, NY: Marcel Dekker Inc; 2000: 651–664.
10. Hoffman B. And then came the microelectrode. Cardiovasc Res. 2002; 53: 1–5.
11. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare in eta pediatrica. Clin Pediatr. 1963; 45: 656–683.
12. Ward OC. A new familial cardiac syndrome in children. J Irish Med Assoc. 1964; 54: 103–106.[Medline] [Order article via Infotrieve]
13. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957; 54: 59–68.[CrossRef][Medline] [Order article via Infotrieve]
14. Schwartz PJ. Prevention of the arrhythmias in the long QT syndrome. In: Kulbertus HE, ed. Medical Management of Cardiac Arrhythmias. Edinburgh, Scotland: Churchill Livingstone; 1986: 153–161.
15. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995; 92: 2929–2934.
16. Antzelevitch C, Yan G-X, Shimizu W, et al. Electrical heterogeneity, the ECG, and cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 3rd ed. Philadelphia, Pa: W.B. Saunders Co; 2000: 222–238.
17. Anyukhovsky EP, Sosunov EA, Gainullin RZ, et al. The controversial M cell. J Cardiovasc Electrophysiol. 1999; 10: 244–260.[Medline] [Order article via Infotrieve]
18. Surawicz B. ST-T abnormalities. In: MacFarlane PW, Lawrie TDV, eds. Comprehensive Electrocardiology: Theory and Practice in Health and Disease.Vol. 1. New York, NY: Pergamon Press; 1989: 511–563.
19. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Circulation. 1991; 84: 1831–1851.
20. Members of the Sicilian Gambit. New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias. Eur Heart J. 2001; 22: 2148–2163.
21. Roden DM, George AL Jr, Bennett PB. Recent advances in understanding the molecular mechanisms of the long QT syndrome. J Cardiovasc Electrophysiol. 1995; 6: 1023–1031.[Medline] [Order article via Infotrieve]
22. Gulbis JM, Zhou M, Mann S, et al. Structure of the cytoplasmic 36 subunit-T1 assembly of voltage-dependent K+ channels. Science. 2000; 289: 123–127.
23. Roux B, MacKinnon R. The cavity and pore helices in the KcsA K+ channel: electrostatic stabilization of monovalent cations. Science. 1999; 285: 100–102.
24. Doyle DA, Morais Cabral J, Pfuetzner RA, et al. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998; 280: 69–77.
25. Chatterjee K, Harris A, Davies G, et al. Electrocardiographic changes subsequent to artificial ventricular depolarization. Br Heart J. 1969; 31: 770–779.
26. Surawicz B. T wave abnormalities. In: Rosenbaum MB, Elizari MV, eds. Frontiers in Cardiac Electrophysiology. Boston, Mass: Martinus Nijhoff Publishing; 1983: 40–66.
27. Engel TR, Shah R, DePodesta LA, et al. T-wave abnormalities of intermittent left bundle-branch block. Ann Intern Med. 1978; 89: 204–206.
28. Denes P, Pick A, Miller RH, et al. A characteristic precordial repolarization abnormality with intermittent left bundle-branch block. Ann Intern Med. 1978; 89: 55–57.
29. Kernohan RJ. Post-paroxysmal tachycardia syndrome. Br Heart J. 1969; 31: 803–806.
30. Levine HD, Lown B, Streeper RB. The clinical significance of postextrasystolic T wave changes. Circulation. 1952; 6: 538–548.[Medline] [Order article via Infotrieve]
31. Nicolai P, Medvedovsky JL, Delaage M, et al. Wolff-Parkinson-White syndrome: T-wave abnormalities during normal pathway conduction. J Electrocardiol. 1981; 14: 295–300.[CrossRef][Medline] [Order article via Infotrieve]
32. Lepeschkin E. Modern Electrocardiography. Baltimore, Md: Williams and Wilkins; 1951: 239–420.
33. Parkinson J, Papp C. Repetitive paroxysmal tachycardia. Br Heart J. 1947; 9: 241–261.
34. Scherf D. Alterations in the T wave with changes in heart rate. Am Heart J. 1944; 28: 332–347.[CrossRef]
35. Rosenbaum MB, Blanco HH, Elizari MV, et al. Electrotonic modulation of the T wave and cardiac memory. Am J Cardiol. 1982; 50: 213–222.[CrossRef][Medline] [Order article via Infotrieve]
36. Rosenbaum MB, Blanco HH, Elizari MV, et al. Electrotonic modulation of ventricular repolarization and cardiac memory. In: Rosenbaum MB, Elizari MV, eds. Frontiers of Cardiac Electrophysiology. Boston, Mass: Martinus Nijhoff Publishing; 1983: 67–99.
37. Szent-Gyorgyi A. Quoted by: Davies RE. The role of ATP in contraction. In: Briller SA, Conn HL, eds. The Myocardial Cell. Philadelphia, Pa: University of Pennsylvania Press; 1966: 157.
38. Shvilkin A, Danilo P Jr, Wang J, et al. Evolution and resolution of long-term cardiac memory. Circulation. 1998; 97: 1810–1817.
39. del Balzo U, Rosen MR. T wave changes persisting after ventricular pacing in canine heart are altered by 4-aminopyridine but not by lidocaine. Circulation. 1992; 85: 1464–1472.
40. Costard-Jackle A, Goetsch B, Antz M, et al. Slow and long-lasting modulation of myocardial repolarization produced by ectopic activation in isolated rabbit hearts: evidence for cardiac "memory." Circulation. 1989; 80: 1412–1420.
41. Yu H, McKinnon D, Dixon JE, et al. Transient outward current, Ito1, is altered in cardiac memory. Circulation. 1999; 99: 1898–1905.
42. Plotnikov AN, Shvilkin A, Xiong W, et al. Interactions between antiarrhythmic drugs and cardiac memory. Cardiovasc Res. 2001; 50: 335–344.
43. Antzelevitch C, Litovsky SH, Lukas A. Epicardium versus endocardium: electrophysiology and pharmacology. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: W.B. Saunders Co; 1990: 386–395.
44. Antzelevitch C, Sicouri S, Litovsky SH, et al. Heterogeneity within the ventricular wall: electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res. 1991; 69: 1427–1449.
45. Geller JC, Rosen MR. Persistent T-wave changes after alteration of the ventricular activation sequence: new insights into cellular mechanisms of "cardiac memory." Circulation. 1993; 88: 1811–1819.
46. Jeck CD, Boyden PA. Age-related appearance of outward currents may contribute to developmental differences in ventricular repolarization. Circ Res. 1992; 71: 1390–1403.
47. Plotnikov AN, Gainullin RZ, Sosunov EA, et al. Age-related development of transient outward current, Ito, is associated with evolution of cardiac memory. Pacing Clin Electrophysiol. 2002; 25: 575.Abstract.
48. Plotnikov AN, Gainullin RZ, Yu H, et al. Cardiac memory depends on a Ca-modulated pathway involving ICa,L. Circulation. 2001; 104 (suppl II): II-110.
49. Patel PM, Plotnikov A, Kanagaratnam P, et al. Altering ventricular activation remodels gap junction distribution in canine heart. J Cardiovasc Electrophysiol. 2001; 12: 570–577.[CrossRef][Medline] [Order article via Infotrieve]
50. Prinzen FW, Augustijn CH, Arts T, et al. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol. 1990; 259: H300–H308.[Medline] [Order article via Infotrieve]
51. Prinzen FW, Hunter WC, Wyman BT, et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999; 33: 1735–1742.
52. Ricard P, Danilo P Jr, Cohen IS, et al. A role for the renin-angiotensin system in the evolution of cardiac memory. J Cardiovasc Electrophysiol. 1999; 10: 545–551.[Medline] [Order article via Infotrieve]
53. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993; 12: 1681–1692.[Medline] [Order article via Infotrieve]
54. Sadoshima J, Qiu Z, Morgan JP, et al. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes: the critical role of Ca2+-dependent signaling. Circ Res. 1995; 76: 1–15.
55. Sadoshima J, Xu Y, Slayter HS, et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993; 75: 977–984.[CrossRef][Medline] [Order article via Infotrieve]
56. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ Res. 1993; 73: 413–423.
57. Yu H, Gao J, Wang H, et al. Effects of the renin-angiotensin system on the current Ito in epicardial and endocardial ventricular myocytes from the canine heart. Circ Res. 2000; 86: 1062–1068.
58. Kass RS, Blair ML. Effects of angiotensin II on membrane current in cardiac Purkinje fibers. J Mol Cell Cardiol. 1981; 13: 797–809.[CrossRef][Medline] [Order article via Infotrieve]
59. Brink M, Price SR, Chrast J, et al. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine-insulin-like growth factor. Endocrinology. 2001; 142: 1489–1496.
60. Wiggers CJ. Willem Einthoven (1860–1927): some facets of his life and work. Circ Res. 1961; 9: 225–234.
61. Kandel ER. Genes, nerve cells, and the remembrance of things past. J Neuropsychiatry Clin Neurosci. 1989; 1: 103–125.
62. Goelet P, Castellucci VF, Schacher S, et al. The long and the short of long-term memory: a molecular framework. Nature. 1986; 322: 419–422.[CrossRef][Medline] [Order article via Infotrieve]
63. Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science. 2001; 294: 1030–1038.
64. Patberg KW, Ferdman DJ, Quamina A, et al. Pacing induces phosphorylation of the cAMP response element binding protein (CREB) and of c-Jun. Pacing Clin Electrophysiol. 2002; 25: 531.Abstract.
65. Patberg KW, Plotnikov AN, Quamina A, et al. Effects of left ventricular pacing on the cAMP response element binding protein (CREB) in canine heart. Circulation. 2001; 104 (suppl II): II-24.
66. Plotnikov AN, Xiong W, Danilo P Jr, et al. The relationship of long-term cardiac memory to changes in ventricular activation, repolarization and effective refractory period. Circulation. 1999; 100 (suppl I): I-50.
67. Satoh T, Zipes DP. Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation. 1996; 94: 217–227.
68. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol. 1996; 7: 833–842.[Medline] [Order article via Infotrieve]
69. Herweg B, Chang F, Chandra P, et al. Cardiac memory in canine atrium: identification and implications. Circulation. 2001; 103: 455–461.
70. Chandra P, Rosen TS, Herweg B, et al. Evolution of the atrial gradient may predict a propensity to atrial tachyarrhythmias. Circulation. 2001; 104 (suppl II): II-109.
71. Chandra P, Rosen TS, Herweg B, et al. Atrial memory: association with atrial fibrillation. Pacing Clin Electrophysiol. 2002; 25: 576.Abstract.
72. Wilson FN, Macleod AG, Barker PS, et al. The determination and significance of the areas of the ventricular deflections of the electrocardiogram. Am Heart J. 1934; 10: 46–61.[CrossRef]
73. Lux RL, Urie PM, Burgess MJ, et al. Variability of the body surface distribution of QRS, ST-T and QRST deflection areas with varied activation sequence in dogs. Cardiovasc Res. 1980; 14: 607–612.[Medline] [Order article via Infotrieve]
74. Abildskov JA. Effects of activation sequence on the local recovery of ventricular excitability in the dog. Circ Res. 1976; 38: 240–243.
75. Hayashi H, Okajima M, Yamada K, Atrial T (Ta) loop in dogs with or without atrial injury. Am Heart J. 1976; 91: 607–617.[CrossRef][Medline] [Order article via Infotrieve]
76. Hayashi H, Okajima M, Yamada K. Atrial T (Ta) loop in patients with A-V block: A trial to differentiate normal and abnormal groups. Am Heart J. 1976; 91: 492–500.[CrossRef][Medline] [Order article via Infotrieve]
77. Einthoven W. The string galvanometer and the measurement of action currents of the heart. Nobel Ed., Physiology or Medicine 1922–1941. New York, NY: Elsevier Publishing Co; 1965.
This article has been cited by other articles:
 |
|
 |
|
  R. Weber dos Santos, A. Nygren, F. Otaviano Campos, H. Koch, and W. R. Giles Experimental and theoretical ventricular electrograms and their relation to electrophysiological gradients in the adult rat heart Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1521 - H1534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Barrett and R. W. Tsien The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels PNAS, February 12, 2008; 105(6): 2157 - 2162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Patberg and M. R. Rosen On the Role of the cAMP Response Element Binding Protein in Long-Term Cardiac Memory Circ. Res., October 31, 2003; 93 (9): e87 - e87. [Full Text] [PDF]
|
|
|
|
|
|
E. J. Folco, K. Roder, G. F. Mitchell, and G. Koren "Cardiac Memory": A Struggle Against Forgetting Circ. Res., September 5, 2003; 93(5): 384 - 386. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||